Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gossamer Bio Inc
(NQ:
GOSS
)
0.9400
+0.0104 (+1.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gossamer Bio Inc
< Previous
1
2
3
4
5
6
Next >
GOSS Stock Earnings: Gossamer Bio Misses EPS, Misses Revenue for Q2 2024
August 12, 2024
GOSS stock results show that Gossamer Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
August 12, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
June 25, 2024
Oppenheimer initiated coverage on Gossamer Bio, highlighting seralutinib's clean long-term safety profile for pulmonary arterial hypertension. Seralutinib shows potential in underserved markets.
Via
Benzinga
Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying
June 25, 2024
Via
Benzinga
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 21, 2024
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
January 08, 2024
Via
Benzinga
The Penny Stock Pundits: 3 Companies Poised to Become the Talk of Wall Street
June 13, 2024
Taking a small position in these penny stocks today could have you sitting on a sizable gain by the time Wall Street starts to pile in.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 11, 2024
Via
Benzinga
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
May 14, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
May 13, 2024
Via
Benzinga
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
GOSS Stock Earnings: Gossamer Bio Misses EPS for Q1 2024
May 07, 2024
GOSS stock results show that Gossamer Bio missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
May 06, 2024
Gossamer Bio partners with Chiesi Farmaceutici to develop and market seralutinib globally, targeting pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung...
Via
Benzinga
Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
May 06, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
May 03, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via
Benzinga
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
March 12, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Goldman Sachs Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
March 06, 2024
Via
Benzinga
GOSS Stock Earnings: Gossamer Bio Meets EPS for Q4 2023
March 05, 2024
GOSS stock results show that Gossamer Bio met analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
March 05, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 20, 2024
Via
Benzinga
7 Micro-Cap Stocks That Could Majorly Surprise Investors
January 31, 2024
Although extremely small enterprises can be terrifyingly risky, these micro-cap stock surprises deserve a closer look.
Via
InvestorPlace
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 08, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 18, 2023
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 18, 2023
Via
Benzinga
Gossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023
December 13, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.